Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2008-05-06
2008-05-06
Ouspenski, Ilia (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S387300
Reexamination Certificate
active
10477525
ABSTRACT:
The present invention relates to CD200 receptor isoforms and modulators thereof and their use in methods of immune modulation and pharmaceutical compositions.
REFERENCES:
patent: WO 00/70045 (2000-11-01), None
Burgess et al., J Cell Biol. 111:2129-2138, 1990.
Lazar et al., Mol Cell Biol. 8:1247-1252, 1988.
Metzler et al., Nature Structural Biol. 1997; 4:527-531.
Bowie et al., Science, 247:1306-1310, 1990.
Blazar et al., J. Immunol., 1996, 157: 3250-3259.
Wright, G.J. et al.,Immunity, vol. 13, 233-242, Aug. 2000.
Barclay, A.N. et al., GENSEQ, Database Accession No. GSP: AAB48017.
Gorczynski Reginald M.
Marsden Philip
Bereskin & Parr
Gravelle Micheline
Ouspenski Ilia
Trillium Therapeutics Inc.
LandOfFree
CD200 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CD200 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CD200 receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3956394